Welcome to our dedicated page for Walgreen Boots news (Ticker: WBA), a resource for investors and traders seeking the latest updates and insights on Walgreen Boots stock.
This page provides a focused view of news and announcements historically associated with Walgreens Boots Alliance, Inc. (formerly Nasdaq: WBA) and its related businesses, including Walgreens and Walgreens Specialty Pharmacy. Company communications highlight Walgreens as a U.S. retail pharmacy brand founded in 1901 that serves nearly 9 million customers and patients each day across approximately 8,500 stores in the U.S. and Puerto Rico, and Walgreens Boots Alliance as a pharmacy-led health and wellbeing enterprise formed through the combination of Walgreens and Alliance Boots.
News related to WBA and Walgreens has covered several key themes. One major area is corporate transactions and capital markets activity. In 2025, a series of announcements detailed the Agreement and Plan of Merger under which Blazing Star Merger Sub, Inc. merged with and into Walgreens Boots Alliance, Inc., resulting in the company becoming a wholly owned subsidiary of Blazing Star Parent, LLC, an affiliate of Sycamore Partners. Related releases described tender offers and consent solicitations for various series of Walgreens Boots Alliance and Walgreen Co. notes, pricing terms, extensions of expiration times and settlement dates, and the final results of these offers.
Another important news category involves the company’s transition from public to private ownership. A Form 8-K filed on August 28, 2025 describes the completion of the merger, the cash consideration and divested asset proceed rights received by shareholders, and the cessation of trading of WBA common stock and certain notes on Nasdaq. A subsequent Form 25 documents the removal of these securities from listing, and a Form 15 filed on September 8, 2025 terminates registration and suspends reporting obligations. Sycamore Partners separately announced the completion of its acquisition of Walgreens Boots Alliance, Inc. and its intention that Walgreens, The Boots Group, Shields Health Solutions, CareCentrix and VillageMD operate as standalone companies under private ownership.
Operational and healthcare-focused news also features prominently. Walgreens Specialty Pharmacy announced an expansion of its limited distribution drug network to 265 products, emphasizing its role in specialty medications for patients with rare, complex and chronic diseases and its independence from pharmacy benefit managers. Walgreens has also issued releases on vaccination services, including nationwide flu shot availability for individuals three years and older, walk-in and scheduled appointments, digital check-in features and incentives for myWalgreens members receiving vaccines.
Investors and observers using this news page can review historical coverage of WBA’s merger process, debt tender offers, governance and shareholder actions, as well as Walgreens’ specialty pharmacy initiatives and vaccination programs. For those tracking the evolution of the company, these articles collectively document WBA’s path from a publicly traded integrated healthcare and retail group to a privately held organization under Sycamore Partners, while also illustrating how Walgreens positions its pharmacies and specialty operations within the broader healthcare landscape.
Walgreens Boots Alliance (WBA) announces a $5.2 billion investment in VillageMD, increasing its ownership stake from 30% to 63%. This investment will enable the opening of over 600 co-located primary care practices within Walgreens stores across more than 30 U.S. markets by 2025, expanding to 1,000 by 2027. The initiative aims to enhance access to primary care, particularly in underserved communities, where more than 75% of Americans live within five miles of a Walgreens location. VillageMD plans to conduct an IPO in 2022.
Walgreens Boots Alliance (WBA) reported strong fourth quarter and fiscal year results, with fourth quarter EPS of $0.41, a 6.4% increase year-over-year, and adjusted EPS up 29.5% to $1.17. Sales from continuing operations rose 12.8% to $34.3 billion, reflecting robust growth across U.S. and International segments. Fiscal 2021 EPS increased significantly to $2.30, with total annual sales of $132.5 billion. Free cash flow for the year was $4.2 billion. The company surpassed its COVID-19 vaccination goal, administering over 34.6 million vaccinations during the fiscal year.
Walgreens Boots Alliance (WBA) has announced two significant executive appointments. Holly May is appointed as the Executive Vice President and Global Chief Human Resources Officer, bringing extensive HR experience from Abercrombie & Fitch and Starbucks. Anita Allemand joins as Chief Transformation and Integration Officer, focusing on healthcare innovation and transformation strategies. Both will report to CEO Roz Brewer. May's start date is set for late October, while Allemand's is October 29, signaling a strategic shift in leadership as the company aims to enhance its healthcare offerings.
Walgreens Boots Alliance (WBA) has reached a significant milestone, distributing life-changing vitamins and minerals to over 300 million women and children worldwide through its partnership with Vitamin Angels since 2013. The company aims to reach 500 million by August 2025. The initiative focuses on providing essential nutrients to at-risk populations, especially in the U.S. and 65 other countries. Additionally, WBA has launched a prenatal vitamin pilot program in Chicago, addressing gaps in access due to inadequate insurance coverage during pregnancy.
No7 Beauty Company, part of Walgreen Boots Alliance, has launched its new Pure Retinol Collection, focusing on gentle skincare solutions. The collection includes a Night Cream and Eye Cream, developed after 15 years of research. Utilizing slow-release encapsulation technology, the products aim to address common concerns like fine lines and dark circles while minimizing irritation. The launch coincides with the ‘We See You’ campaign, emphasizing inclusivity for women historically underrepresented in the beauty sector.
Walgreens and Safeguard have launched the Hope is in Your Hands program, donating $300,000 worth of hand hygiene essentials to underserved communities. This initiative aims to distribute 10 million handwashes through Americares, an organization focused on health relief. The program is critical as CDC emphasizes handwashing to prevent illnesses, especially amid the ongoing COVID-19 pandemic. The products will be distributed via partner clinics in the U.S. and globally, enhancing access to essential hygiene items for low-income families.
Walgreens has announced that eligible individuals can now receive Pfizer COVID-19 booster vaccinations along with flu shots in stores across the U.S. This follows FDA Emergency Use Authorization and CDC guidance. Eligible populations include individuals aged 65 and older, those in long-term care, and others with underlying conditions. Patients can schedule appointments through Walgreens' website or by phone. Additionally, Walgreens is offering a $5 reward for those who receive vaccinations in-store, promoting community health and convenience.
Walgreens Boots Alliance (WBA) has announced a majority investment of approximately $970 million in Shields Health Solutions, increasing its ownership to 71%. This partnership aims to enhance innovative healthcare models and further develop health system partnerships, particularly in managing complex chronic conditions. Following this investment, Shields will operate independently while its financials will be consolidated by WBA, potentially becoming modestly accretive in its first full year. The transaction is expected to close by the end of WBA's second fiscal quarter in 2022.
Walgreens has announced new bonuses and rewards for its pharmacy teams, including a $1,250 bonus for full-time pharmacists and $1,000 for part-time pharmacists, to be paid in September 2021. Certified pharmacy technicians will also receive a $1,000 reward if they administer flu and COVID-19 vaccines. Additionally, Walgreens is incentivizing team members with $200 in myWalgreens cash for COVID-19 vaccinations completed by November 30, 2021. These initiatives aim to support employee dedication amidst ongoing COVID-19 efforts.
Walgreens (WBA) and Northwell Health announced a five-year strategic affiliation aimed at enhancing health equity and improving the health of populations in New York State. This partnership will focus on innovative health care delivery models that reduce costs and improve access and quality of care. Collaborative efforts include digital services, retail pharmacy offerings, and making Walgreens an in-network pharmacy for Northwell employees. This initiative also aims to expand telehealth services and explore retail health clinics in underserved areas.